Amarin Corp Plc (AMRN)

[roadkilll]

Guess that answers the question of will there be significant infringement of the use patent simply be marketing a generic.
Hundreds of millions spent to comply with FDA to get the CV patent and to educate public and health officials going down the drain due to a lazy patent judge. Luckily the patent lawsuits keep the generic launch at risk.

Willful blindness by insurers looks like the most obvious court case.